23.01.2025 10:55:38
|
EQS-AFR: Heidelberg Pharma AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
EQS Preliminary announcement financial reports: Heidelberg Pharma AG
/ Preliminary announcement on the disclosure of financial statements
Heidelberg Pharma AG hereby announces that the following financial reports shall be disclosed:
Report Type: Annual financial report Language: German Date of disclosure: March 21, 2025 Address: https://heidelberg-pharma.com/de/presse-investoren/mitteilungen-und-berichte/finanzberichte Language: English Date of disclosure: March 21, 2025 Address: https://heidelberg-pharma.com/en/press-investors/announcements/financial-reports Report Type: Annual financial report of the group Language: German Date of disclosure: March 21, 2025 Address: https://heidelberg-pharma.com/de/presse-investoren/mitteilungen-und-berichte/finanzberichte Language: English Date of disclosure: March 21, 2025 Address: https://heidelberg-pharma.com/en/press-investors/announcements/financial-reports Report Type: Financial report of the group (half-year/Q2) Language: German Date of disclosure: July 10, 2025 Address: https://heidelberg-pharma.com/de/presse-investoren/mitteilungen-und-berichte/finanzberichte Language: English Date of disclosure: July 10, 2025 Address: https://heidelberg-pharma.com/en/press-investors/announcements/financial-reports
23.01.2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | Heidelberg Pharma AG |
Gregor-Mendel-Str. 22 | |
68526 Ladenburg | |
Germany | |
Internet: | www.heidelberg-pharma.com |
End of News | EQS News Service |
|
2073631 23.01.2025 CET/CEST

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Heidelberg Pharma AGmehr Nachrichten
Analysen zu Heidelberg Pharma AGmehr Analysen
Aktien in diesem Artikel
Heidelberg Pharma AG | 2,60 | -2,26% |
|